Two Sigma Securities’s Fulgent Genetics FLGT Stock Holding History

Two Sigma Securities’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,387	Closed	-$238K	–	2848
2022 Q4	$220K	Buy	+7,387	New	+$264K	0.01%	1857

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Securities's FLGT Position: Q1 2023 in Review

Two Sigma Securities sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 7,387 shares — an estimated $238K sold.

Two Sigma Securities first reported a position in FLGT in Q4 2022 and held it in 1 quarter. The position peaked at $220K in Q4 2022. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

Two Sigma Securities reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
Two Sigma Securities sold 7,387 Fulgent Genetics shares in Q1 2023, an estimated $238K.
Two Sigma Securities first reported a position in Fulgent Genetics in Q4 2022 and held it in 1 quarter.
Two Sigma Securities's Fulgent Genetics position peaked at $220K in Q4 2022.
215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.